$ENOV

Colfax CORP

CIK:0001420800|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 03, 2026	Jul. 04, 2025	Jul. 03, 2026	Jul. 04, 2025
Income Statement [Abstract]
Net sales	$ 582,782	$ 564,545	$ 1,171,933	$ 1,123,379
Cost of sales	223,533	229,848	447,199	456,453
Gross profit	359,249	334,697	724,734	666,926
Selling, general and administrative expense	263,730	267,074	546,540	536,093
Research and development expense	31,686	30,700	63,219	59,228
Amortization of acquired intangibles	41,561	42,962	83,465	84,774
Purchase of royalty interest	0	10,041	0	45,818
Restructuring charges	4,859	716	7,567	4,578
Operating income (loss)	17,413	(16,796)	23,943	(63,565)
Interest expense, net	8,038	9,294	17,207	18,482
Other (income) expense, net	1,910	(436)	(1,363)	956
Income (loss) from continuing operations before income taxes	7,465	(25,654)	8,099	(83,003)
Income tax expense	8,501	10,801	17,546	9,032
Net loss from continuing operations	(1,036)	(36,455)	(9,447)	(92,035)
Loss from discontinued operations, net of taxes	0	(93)	(39)	(218)
Net loss	(1,036)	(36,548)	(9,486)	(92,253)
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes	154	191	468	452
Net loss attributable to Enovis Corporation	$ (1,190)	$ (36,739)	$ (9,954)	$ (92,705)
Earnings Per Share, Basic [Abstract]
Net income (loss) per share, continuing operations, basic (in usd per share)	$ (0.02)	$ (0.64)	$ (0.17)	$ (1.62)
Net income (loss) per share, continuing operations, diluted (in usd per share)	(0.02)	(0.64)	(0.17)	(1.62)
Net income (loss) per share, consolidated, basic (in usd per share)	(0.02)	(0.64)	(0.17)	(1.62)
Net income (loss) per share, consolidated, diluted (in usd per share)	$ (0.02)	$ (0.64)	$ (0.17)	$ (1.62)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 03, 2026	Jul. 04, 2025
Cash flows from operating activities:
Net income (loss)	$ (9,486)	$ (92,253)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	144,381	142,986
Stock-based compensation expense	17,718	16,075
Non-cash interest expense	3,506	3,203
Fair value loss on contingent acquisition shares	0	1,787
Deferred income tax benefit	(42,200)	(3,673)
Loss on sale of property, plant and equipment	768	848
Changes in operating assets and liabilities:
Trade receivables, net	(3,263)	(20,824)
Inventories, net	(21,742)	(57,282)
Accounts payable	4,980	23,161
Other operating assets and liabilities	4,321	32,145
Net cash provided by operating activities	98,983	46,173
Cash flows from investing activities:
Purchases of property, plant and equipment and intangibles	(96,699)	(87,631)
Payments for acquisitions, net of cash received, and investments	(1,407)	(24,290)
Cash received upon settlement of derivatives	0	1,601
Net cash used in investing activities	(98,106)	(110,320)
Cash flows from financing activities:
Repayments of borrowings under term credit facility	(17,500)	(10,000)
Proceeds from borrowings on revolving credit facilities and other	104,388	127,000
Repayments of borrowings on revolving credit facilities and other	(101,897)	(54,995)
Payments of tax withholding for stock-based awards	(1,473)	(3,447)
Proceeds from issuance of common stock, net	1,008	1,129
Deferred consideration payments and other	(9,068)	(2,265)
Net cash provided by (used in) financing activities	(24,542)	57,422
Effect of foreign exchange rates on Cash and cash equivalents	(161)	2,632
Decrease in Cash and cash equivalents	(23,826)	(4,093)
Cash and cash equivalents, beginning of period	36,389	48,167
Cash and cash equivalents, end of period	$ 12,563	$ 44,074

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 03, 2026	Dec. 31, 2025
ASSETS
Cash and cash equivalents	$ 12,563	$ 36,389
Trade receivable, less allowance for credit losses	441,846	442,786
Inventories, net	601,660	584,379
Prepaid expenses	48,505	42,283
Other current assets	110,116	101,222
Total current assets	1,214,690	1,207,059
Property, plant and equipment, net	527,534	507,063
Goodwill	709,853	718,299
Intangible assets, net	1,150,319	1,236,713
Lease asset - right of use	74,836	72,256
Other assets	88,894	93,347
Total assets	3,766,126	3,834,737
LIABILITIES AND EQUITY
Current portion of long-term debt	37,388	35,000
Accounts payable	194,472	187,531
Accrued liabilities	380,191	375,943
Total current liabilities	612,051	598,474
Long-term debt, less current portion	1,247,120	1,261,793
Non-current lease liability	59,160	58,000
Other liabilities	368,630	424,568
Total liabilities	2,286,961	2,342,835
Equity:
Common stock, $0.001 par value; 133,333,333 shares authorized; 57,665,074 and 57,194,781 shares issued and outstanding as of July 3, 2026 and December 31, 2025, respectively	58	57
Additional paid-in capital	3,065,667	3,048,414
Accumulated deficit	(1,477,417)	(1,467,463)
Accumulated other comprehensive loss	(111,241)	(91,363)
Total Enovis Corporation equity	1,477,067	1,489,645
Noncontrolling interest	2,098	2,257
Total equity	1,479,165	1,491,902
Total liabilities and equity	$ 3,766,126	$ 3,834,737